Sunnyvale, CA, United States of America

Narmada R Shenoy

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2001-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Narmada R Shenoy: Innovator in Pharmaceutical Compositions

Introduction

Narmada R Shenoy, an accomplished inventor based in Sunnyvale, California, has significantly contributed to the field of pharmaceuticals. With a total of six patents to her name, Shenoy's work focuses on innovative solutions for cardiovascular diseases and lipid-related disorders.

Latest Patents

Among her most notable inventions are pharmaceutical compositions for substituted quinazolinones. Her latest patent describes novel solid pharmaceutical formulations and methods for their preparation. The formulations aim to regulate the expression of apolipoprotein A-I (ApoA-I), which is critical in the treatment and prevention of cardiovascular disease and related conditions, including atherosclerosis and other cholesterol- or lipid-related disorders.

Career Highlights

Narmada has worked for prominent companies such as Sugen Incorporated and Resverlogix Corporation. Her experience in these organizations has undoubtedly enriched her expertise, leading to her development of innovative pharmaceutical solutions that address pressing health issues.

Collaborations

Throughout her career, Narmada has collaborated with noteworthy colleagues, such as Gregory Steven Wagner and Waranush Sorasuchart. These partnerships have played a vital role in nurturing her innovative ideas and bringing her patents to fruition.

Conclusion

With her keen insights and persistence in overcoming health challenges, Narmada R Shenoy continues to make a profound impact in the pharmaceutical industry. Her contributions not only pave the way for new treatments but also inspire the next generation of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…